Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
04:03a BOC HONG KONG : Alert on Fake Email and Fraudulent Website
04:03a INCHCAPE : Directorate Change
04:03a SOFTBANK : Announcement of Executive Appointment and Personnel Changes
04:03a GLOBE TRADE CENTRE : sells Kazimierz Office Center for 42 million euro
04:03a LC : Notification given pursuant to Art. 160 of the Act on Trading in Financial instruments.
04:03a SHANGHAI TONVA PETROCHEMICAL : Next Day Disclosure Returns - Next Day Disclosure Return
04:03a INTERCONTINENTAL HOTELS : Ihg launches ihg® business rewards
04:03a CXENSE ASA : Japanese Media Management Business FourM Licenses Cxense Insight
04:03a AIRBUS : Helicopters signs first HCare Fleet Availability contract in Asia with Taiwan’s National Airborne Services Corps
04:03a INMARSAT : Global Xpress is coming to China
Latest news
Advertisement
Hot News 
REAL GOOD FOOD : Trading Update
NATUREX : Number of shares and voting rights as at 31 January 2015
MCH : Media Release | MCH Group | Result 2014
AMERISUR RESOURCES : Confident Of Recovering Reserves After It Reports Large Drop
INNOVATION : Shares Plunge As Contract Delays Offset Sale Proceeds
Most Read News
03/31 Wall St. drops but S&P, Nasdaq register quarterly gains
03/31 DEUTSCHE LUFTHANSA : Nick Clegg: don’t let Andreas Lubitz distort views about mental illness
03/31 FOREMOST INCOME FUND : Reports 2014 Results
03/31 NEW FLYER : Winnipeg Bargaining Unit Collective Bargaining Agreement Extension
03/31 SHANTA GOLD : New Loan Facilities
Most recommended articles
04:01a Japan debt/GDP to worsen from 2023 even with strong growth - sources
03:57a French manufacturing contraction eases in March - PMI
03:57a French March car sales rose 9.3 percent - CCFA
03:56aDJFrench Car Sales Jump 9.3% on Year in March
03:48a Japan's Sony Corp. halves stake in Olympus
Dynamic quotes  
ON
| OFF